You are here: > Resources > Generic Drugs Hit Backlog At FDA: N...

Generic Drugs Hit Backlog At FDA: No Plans to Expand Review Capabilities

Date: February 4, 2006
Author: Marc Kaufman
QUOTE: "The branded industry has to be delighted by this backlog," said Jake Hansen, vice president for government affairs for Barr Laboratories Inc., a maker of generic drugs. "If they can't stop competition in the courts, stopping it as applications go through the regulatory process is just as effective..."

Article MetaInformation:

Key People:
Key Organizations:
Subject & Geographic Categories:


*User comments are posted without LLC's prior review or approval, and LLC takes no responsibility for them; please see our Conditions of Service Agreement.